Introduction
Neuropathic pain is characterized by exaggerated response to noxious stimuli (hyperalgesia), pain response to normally innocuous stimuli (allodynia) and spontaneous pain (48, 49) . Neuropathic pain has long been considered as a disease of the nervous system (2) and has been intensively studied for many years. However, effective treatment for the disease is still unmet.
A previous study has shown that intrathecal injection of diazepam reduced inflammatory heat hyperalgesia, as well as chronic constriction injury (CCI)-induced heat hyperalgesia, cold allodynia and mechanical sensitization in mice (19) . Our recent work has also shown that diazepam depresses early as well as late phase long-term potential (LTP) of C-fiber-evoked field potentials (12) , which is proposed as a synaptic model of hyperalgesia (13, 38) . These results suggest that diazepam applied locally could inhibit neuropathic pain, but whether similar antinociceptive effects can also be achieved by a single intraperitoneal administration and the mechanisms are still unclear.
There are two types of receptors for diazepam, the central benzodiazepine receptor (CBR) and the translocator protein (TSPO). CBR is coupled to type A α-aminobutyric acid (GABAA) receptor, and is present exclusively in the CNS being localized on neurons (51) . Benzodiazepines bind to a domain that regulates chloride flux by modulating GABA binding to GABAA receptors (30) . It has been reported that the CBR agonist, octadecaneuropeptide (ODN), can stimulate neurosteroids biosynthesis through activation of CBR (8, 9) . TSPO, which was once named the peripheral benzodiazepine receptor (31) , is present in many tissues including endocrine steroidogenic tissues (32) , cells of the immune system (52) and neurons and glia cells (43) . TSPO could also promote the synthesis of neurosteroids, including pregnenolone, progesterone, allopregnanolone and dehydroepiandrosterone, which play important roles in pain modulation (25, 26) . Some studies have shown that acute diazepam treatments (10.0 mg/kg or 20.0 mg/kg) but not long-term diazepam treatment (10.0 mg/kg) reduced carrageenan-induced paw edema volume, and that this effect was attributed to the presence of TSPO in the adrenal and immune cells (21, 22) . Our previous study has shown that TSPO was up-regulated after L5 SNL and neuropathic pain was depressed by its agonists, suggesting that TSPO may be induced to counteract the hyperexcitability in neuropathic pain states (43) . Diazepam has been reported to show similar high affinity to the CBR and TSPO (40) . The results have led us to speculate that diazepam, which acts on CBR, as well as TSPO, may exert protective effects against neuropathic pain by promoting the synthesis of neurosteroids.
Activation of astrocytes may be involved in the maintenance of neuropathic pain by releasing proinflammatory cytokines such as tumor necrosis factoralpha (TNF-α), IL-1β and interleukin-6 (IL-6) (41). It has also been shown that treatment with diazepam decreases interleukin release from lymphocytes (35) , and that neurosteroid progesterone can reduce the expression of TNF-α and IL-1β in cultured microglia (14) . However, whether intraperitoneal injection of diazepam could inhibit the production of IL-1β in the spinal dorsal horn by promoting neurosteroid synthesis is still unknown.
In the present study, we first investigated whether a single intraperitoneal injection of diazepam (5.0 mg/kg) or Ro5-4864 (5.0 mg/kg) could inhibit neuropathic pain. We then investigated whether CBR mediated the effect of diazepam on neuropathic pain. Next, we investigated whether a neurosteroid synthesis inhibitor could block the effects of diazepam and Ro5-4864. Further experiments were also done to test whether a single intraperitoneal injection of pregnenolone (5.0 mg/kg), a neuroactive steroid precursor, could inhibit neuropathic pain. Lastly, whether intraperitoneal injection of diazepam, Ro5-4864 or pregnenolone could inhibit the activation of astrocytes and subsequent production of IL-1β in L5 spinal dorsal horn induced by L5 SNL was investigated.
Materials and Methods

Animals
Adult male Sprague Dawley rats (Guangzhou, PRC) weighing 200-220 g were housed in separated cages under a 12/12 light/dark cycle with access to food and water ad libitum. The room temperature was controlled at 24 ± 1°C and 50-60% humidity. The studies were approved by the Institutional Animal Care and Use Committee at the Sun Yat-Sen University, and all experimental procedures were performed in accordance with the guideline of the National Institutes of Health on animal care and the ethical guidelines for study of pain (53) .
Drugs Administration
Diazepam, Ro5-4864 (7-chloro-5-4-chlorophenyl)-1,3-dihydro-1-methyl-2-H-1,4-benzodiaze-pine-2), and AMG (R(+)-p-aminoglutethimide) (Sigma, St. Louis, MO, USA) were dissolved and stored as a 0.1 M stock solution at -20°C, and was diluted in sterile PBS to the appropriate concentration immediately before administration. The drug vehicles, propylene glycol (for diazepam), dimethyl sulfoxide (DMSO) for Ro5-4864 and AMG were used as controls, which had no discernable effects on the behavioral responses when injected. Pregnenolone (LKT LABs, St. Paul, MN, USA) was dissolved in minimal Tween 80, and diluted in sterile PBS to the appropriate concentration immediately before administration. Flumazenil (Sigma) was suspended in physiological saline containing 9% Tween 80 and was injected intraperitoneally (i.p.) in a total volume of 200 µl.
Surgical Procedures
The L5 transverse process was removed to expose the L5 spinal nerve, which was then isolated carefully and ligated tightly with 6-0 silk thread 5-10 mm distal to the L5 DRG as described previously (18) . The animals in the sham operation group received the same operation except for ligation of the nerve. A complete hemostasis was confirmed and the wound was sutured in two layers. Rats with hind limb paralysis or paresis after surgery were excluded.
Behavioral Tests
Animals were habituated and basal pain sensitivity was tested before drug administration or surgery. Mechanical sensitivity was assessed with the up-down method described previously (5), using a set of von Frey hairs with logarithmically incremental stiffness from 0.6-15 g (0.6, 1, 1.4, 2, 4, 6, 8, 15 g). The 2 g stimulus, in the middle of the series, was applied first. In the event of absence of paw withdrawal, the next stronger stimulus was chosen. On the contrary, a weaker stimulus was applied. Each stimulus consisted of a 6 to 8 s application of the von Frey hair to the sciatic innervation area of the hind paws with a 5-min interval between stimuli. The quick withdrawal or licking on the paw in response to the stimulus was considered as a positive response.
Heat hypersensitivity was tested using the plantar test (7370, UgoBasile, Comeria, Italy). Briefly, a radiant heat source beneath a glass floor was aimed at the plantar surface of the hind paw. Three measurements of latency were taken for each hind paw in each test session. The hind paw was tested alternately with longer than 5-min intervals. The three measurements of latency per side were averaged as the result of per test.
Western Blotting
The dorsal quadrants of L5 spinal cord were harvested from different groups of rats (six rats at each group). The ipsilateral sides were separated and put into liquid nitrogen immediately, followed by homogenization in 15 mM Tris buffer, pH 7.6 [250 mM sucrose, 1 mM MgCl, 1 mM DTT, 2.5 mM EDTA, 1 mM EGTA, 50 mM NaF, 10 μg/ml leupeptin, 1.25 μg/ml pepstatin, 2.5 μg/ml aprotin, 2 mM sodium pyrophosphate, 0.1 mM NaVO4, 0.5 mM PMSF, and protease inhibitor cocktail (Roche Molecular Biochemicals)]. The tissues were sonicated on ice, and then centrifuged at 13,000 × g for 15 min at 4°C to isolate the supernatant containing protein samples.
Proteins were separated by gel electrophoresis (SDS-PAGE) and transferred onto a PVDF membrane (Bio-Rad). The blots were blocked with 5% w/v nonfat dry milk in TBST (20 mM Tris-base, pH 7.6, 137 mM NaCl and 0.1% Tween 20) for 1 h at room temperature and then incubated with primary rabbit polyclonal anti-IL-1β antibody (1:1000, Abcam, UK) and rabbit polyclonal anti-mouse β-actin antibody (1:1000, Cell Signaling Technology Danvers, MA, USA) overnight at 4°C with gentle shaking. The blots were washed three times for 10 min each with washing buffer (TBST) and then incubated with a secondary antibody horseradish peroxidase (HRP)-conjugated goat anti-rabbit or goat anti-mouse IgG (1:8000 or 1:5000, Cell Signaling Technology) for 2 h at room temperature. After incubation with the secondary antibody, the membrane was washed again as above. The immune complex was detected by ECL (GE Healthcare, Piscataway, NJ, USA) and exposed to x-ray film. The band intensities on the film were analyzed by densitometry with a computer-assisted imaging analysis system (KONTRON IBAS 2.0 Eching, Germany).
Immunohistochemistry
Rats were perfused through the ascending aorta with saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2-7.4, at 4°C. The L5 spinal cord segments were removed and post-fixed in the same fixative for 3 h and then replaced with 30% of sucrose overnight. Transverse free-floating spinal sections (25 µm) were cut in a cryostat (Leica CM 1900, Heidelberg, Germany) and processed for immunostaining with immunofluorescence according to the method described previously (45) . All of the cryostat sections were blocked with 3% donkey serum in 0.3% Triton X-100 for 1 h at room temperature and incubated overnight at 4°C with mouse monoclonal glial fibrillary acidic protein (GFAP), an astrocyte marker (1:300; Chemicon, Temecula, CA, USA). The sections were then incubated for 1 h at room temperature with FITC-conjugated secondary antibody (1:400; Jackson ImmunoResearch, West Grove, PA, USA). The stained sections were examined with an Olympus IX71 (Olympus Optical, Tokyo, Japan) fluorescence microscope and images were captured with a CCD spot camera.
Quantification and Statistics
For quantification of the immunofluorescence staining, the area of GFAP -immunoreactivity (IR) per section was measured using a Leica Qwin V3 digital image processing system (Leica, Wetzlar, Germany). A density threshold was first set above the background level to identify positively-stained structure. The area occupied by these structures was measured as a positive area. In each rat, every fifth section was picked from a series of consecutive sections; and four to six sections at each time point were randomly selected. An average percentage of area of GFAP-IR relative to the total area of the sections was obtained for each animal across the different tissue sections, and was normalized to the control values. Six rats were included for each group for quantification of immunohistochemistry results.
All analysis was done in a blinded fashion with the same criterion. All data were expressed as means ± SEM. For the data of behavioral tests, nonparametric tests were employed in comparison between various testing days. For immunofluorescence data, differences in changes of values over time were tested using one-way ANOVA followed by individual post hoc comparisons (Tukey post hoc tests). The relative densities of western blots between different groups were compared using ANOVA with the least significant difference test (LSD-t). Statistical tests were taken with SPSS 10.0 (SPSS Inc., Chicago, IL, USA). A difference was accepted as significant if the P value is less than 0.05.
Results
A Single Intraperitoneal Injection of Diazepam or Ro5-4864 Reversed Neuropathic Pain Induced by L5 SNL
A significant decrease in 50% paw withdrawal threshold (50% PWT, Fig. 1A ) and paw withdrawal latency (PWL, Fig. 1B ) on the ipsilateral side was detected 4 d after L5 SNL, compared with pre-operative baseline, showing that prominent mechanical allodynia and thermal hyperalgesia was established. The changes were maintained for 4-5 weeks after operation, which were consistent with our previous work (18) . To investigate the effect of diazepam on the behavioral signs of neuropathic pain, a single intraperitoneal injection of diazepam (5 mg/kg) was done 9 d after L5 SNL, and the 50% PWT and PWL were tested before and after the treatment. One day after diazepam treatment, the 50% PWT (P < 0.01 vs. predrug) and PWL (P < 0.001 vs. predrug) were already significantly increased, almost to the normal range characteristic of sham animals, and the effects persist until the end of the experiment (33 d after the drug injection, that is 42 d after L5 SNL) (Fig. 1, A and B) . In contrast, in propylene glycol (which was used to dissolve diazepam)-treated L5 SNL rats, no change was detected (P > 0.05 vs. predrug, n = 7) (Fig. 1, A and B) .
To test whether TSPO, a diazepam receptor, participates in neuropathic pain, a TSPO agonist, Ro5-4864 (5 mg/kg) was injected intraperitoneally 9 d after L5 SNL. The results showed that a single injection of Ro5-4864 significantly inhibited the decrease of 50% PWT (Fig. 1C , P < 0.001 vs. predrug) and the decrease in PWL (Fig. 1D , P < 0.001 vs. predrug) produced by L5 SNL, and the effect also persisted until the end of the experiment. Treatment with the vehicle DMSO had no effect on the decrease of 50% PWT and PWL (Fig.  1, C and D, n = 5).
Pretreatment with CBR Antagonist Flumazenil Blocked the Effects of Diazepam on Neuropathic Pain
To investigate whether CBR is involved in the effects of diazepam on neuropathic pain, a specific CBR antagonist, flumazenil (5 mg/kg, i.p.) was injected 30 min before intraperitoneal injection of diazepam at day 9 after L5 SNL. Flumazenil pretreatment could completely prevent the increase in 50% PWT and PWL in the ipsilateral side following intraperitoneal injection of diazepam (Fig. 2, A and B , P > 0.05 vs. predrug), while vehicle pretreatment had no effect on the increase in 50% PWT and PWL (P < 0.01 vs. predrug), which increased significantly to the levels that were not different from those measured before L5 SNL (P > 0.05).
Pretreatment with Neurosteroid Synthesis Inhibitor AMG Blocked the Effects of Diazepam and
Ro5-4864 on Neuropathic Pain
It has been shown that both CBR and TSPO function via promotion of neurosteroidogenesis (8, 9, 29) . To investigate whether synthesis of neurosteroid is also involved in the effects of diazepam and Ro5-4864 on neuropathic pain, a neurosteroid synthesis inhibitor, AMG (10 mg/kg, i.p.), was injected intraperitoneally 30 min before intraperitoneal injection of diazepam or Ro5-4864. In the AMG-treated group, 50% PWT and PWL in the ipsilateral side did not change following intraperitoneal injection of either diazepam (Fig. 3, A and B , P > 0.05 vs. predrug) or Ro5-4864 (Fig. 3 , C and D, P > 0.05 vs. predrug), while in rats pretreated with DMSO, which was used to dissolve AMG, both 50% PWT and PWL increased significantly (P < 0.01 vs. predrug) to the levels that were not different from those measured before L5 SNL (P > 0.05).
A Single Intraperitoneal Injection of Pregnenolone Reversed Neuropathic Pain Induced by L5 SNL
To further test whether neurosteroids participate in neuropathic pain, a neurosteroid precursor, pregnenolone, which is also the most abundant neurosteroid produced in the neural tissue of rats and humans (3, 24) , was injected intraperitoneally (5 mg/kg) 9 d after L5 SNL. The results showed that a single injection of pregnenolone also significantly inhibited the decrease in 50% PWT (Fig. 4A) and PWL (Fig. 4B) induced by L5 SNL, and the effect persisted until the end of experiment, which was comparable to diazepam and Ro5-4864. Treatment with the vehicle Tween-80 *** *** *** *** *** *** *** *** *** ** had no effect on the established mechanical allodynia (Fig. 4A ) and thermal hyperalgesia (Fig. 4B) .
A Single Intraperitoneal Injection of Diazepam, Ro5-4864 or Pregnenolone Inhibited the Activation of Astrocytes in the L5 Spinal Dorsal Horn
Activation of astrocytes in the spinal cord is important for the maintenance of neuropathic pain (41) . In the present study, we next investigated whether a single intraperitoneal of diazepam, Ro5-4864 or pregnenolone affect the activation of astrocytes in the ipsilateral L5 spinal dorsal horn induced by L5 SNL with use of immunohistochemistry. Compared with the sham group (Fig. 5, A , D and G) 14 d after L5 SNL, astrocytes were significantly activated in the ipsilateral L5 spinal dorsal horn, manifesting as overexpression of GFAP (Fig. 5, B , E and H, P < 0.001, vehicle-treated L5 SNL group vs. sham). The activation of astrocytes produced by L5 SNL was suppressed by diazepam (Fig. 5, C and J) , Ro5-4864 (Fig. 5, F and K) or pregnenolone (Fig. 5, I and L) administrated 5 d before (14 d after L5 SNL, P < 0.001, drug treated group vs. vehicle treated group).
A Single Intraperitoneal Injection of Diazepam, Ro5-4864 or Pregnenolone Reduced the Production of IL-1β in the L5 Spinal Dorsal Horn
IL-1β, which has a long lasting effect (44) than TNFα (45) , may contribute to the development and maintenance of neuropathic pain by multiple mech- 
Discussion
In the present study, we showed that a single intraperitoneal injection of diazepam significantly inhibited the established mechanical allodynia and thermal hyperalgesia induced by L5 SNL for at least 3 weeks. Flumazenil, a specific antagonist, could completely prevent the inhibitory effect of diazepam on neuropathic pain. A single intraperitoneal injection of the TSPO agonist Ro5-4864 or the neurosteroid precursor, pregnenolone, could mimic the effects of diazepam on neuropathic pain. Importantly, pretreatment with AMG, a neurosteroid synthesis inhibitor, significantly abolished the effects of diazepam and Ro5-4864. Further more, each of the three drugs, diazepam, Ro5-4864 and pregnenolone, reduced activation of astrocytes and the production of an important cytokine, IL-1β, in the L5 spinal dorsal horn induced by L5 SNL. These results suggest that diazepam might inhibit neuropathic pain via activation of CBR and TSPO, which then inhibited the activation of astrocytes and the production of IL-1βin the spinal dorsal horn by promoting the synthesis of neurosteroids.
Diazepam May Inhibit Neuropathic Pain via CBR-and TSPO-Mediated Neurosteroid Synthesis
In the present study, we found that a single intraperineal injection of diazepam could inhibit the neuropathic pain even 3 weeks after the injection, when diazepam injected had been eliminated from the circulation in the rats. One possibility why diazepam had such a lasting effect is that it induced a persistent synthesis of chemicals, thus changing the residing environment that of the neurons.
It has been reported that activation of CBR can stimulate neurosteroids biosynthesis (8, 9) . In the present study, we found that pretreatment with flumazenil, a specific CBR antagonist, completely prevented the inhibitory effect of diazepam on neuropathic pain induced by L5 SNL. Thus, diazepam may also promote the synthesis of neurosteroids via CBR. Diazepam also binds to TSPO with high affinity (40) . Our previous study has demonstrated that TSPO is upregulated in spinal dorsal horn following L5 SNL, and that a single intrathecal injection of TSPO-specific agonists (either Ro5-4864 or FGIN-1-27) clearly inhibited neuropathic pain (43) . In the present study, we also found that a single intraperineal injection of Ro5-4864 inhibited L5 SNL induced neuropathic pain, and the effects was comparable to diazepam, suggest- ing that TSPO may also contribue to the beneficial effects of a single injection of diazepam on neuropathic pain. This is consistent with previous studies showing that acute diazepam treatments (10.0 or 20.0 mg/kg) reduce carrageenan-induced paw edema volume, and that this effect is attributed to an action of diazepam on the TSPO (21, 22) . Thus, the neurosteroid synthesis following CBR and TSPO activation is necessary for the long lasting effect of diazepam on neuropathic pain (Fig. 7) .
The synthesis of neuroactive steroids, including pregnenolone, progesterone, allopregnanolone, and dehydroepiandrosterone, could be promoted by TSPO (37) . Pregnenolone, as a precursor of all steroids, may Previous data have indicated that a substantial part of the steroid metabolites such as progesterone may be also synthesized in the CNS from the steroid precursors, or directly transported through blood brain barrier (BBB) from the periphery, modulating the function of neurons (15) . In the present study, we found that diazepam, Ro5-4864 or pregnenolone each had similar effects on neuropathic pain, astrocytes activation and IL-1β expression. Furthermore, the neurosteroid synthesis inhibitor AMG that specifically blocks P450 side-chain cleavage, which converts cholesterol into pregnenolone (the precursor for the biosynthesis of all steroid hormone), prevented the effects of diazepam or Ro5-4864 on neuropathic pain. These results suggest that these drugs inhibit neuropathic pain by inducing the same targets, that is, neurosteroids. Multiple mechanisms may be involved in the inhibitory effects of neurosteroids on neuropathic pain. Neuropathic pain has been associated with reduced spinal gamma-aminobutyric acid (GABA)-ergic inhibitory function. Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury (10) . Previous studies have revealed that neurosteroids interact with an allosterically coupled binding complex of the GABAA chloride ionophore. This coupling augments the GABA-initiated opening of the channel. At higher concentrations, these neurosteroids directly activate the GABAA receptor channel complex (4). It has also been shown that progesterone prevents the injury-induced upregulation of N-methyl-D-aspartate receptor subunits and protein kinase C gamma RNA (6) , and that allopregnanolone attenuates neuropathic pain by blocking T-type calcium channels (33, 34) . Neurosteroids have also been shown to interact with glycine receptor mediated chloride currents (27, 28, 46) .
Diazepam May Inhibit Neuropathic Pain by Inhibiting Neuroinflammation
It has been demonstrated that cytokines, including TNF-α, IL-1β and IL-6, play important roles in neuropathic pain (7) . Our previous studies have shown that application of recombinant rat TNF-α or IL-1β to the healthy sciatic nerve could induce mechanical allodynia (44, 45) , and that inhibition either of TNF-α or IL-6 could alleviate neuropathic pain following L5 ventral root transection (42, 50) . In the present study, we found that a single intraperitoneal injection of diazepam 9 d after L5 SNL inhibited the production of IL-1β, one of the important cytokines, and the effects were mimicked by Ro5-4864 or pregnenolone, suggesting that TSPO-mediated anti-inflammatory effects may contribute to the effects of diazepam on neuropathic pain (Fig. 7) . These results are also consistent with previous studies showing that diazepam could inhibit the release of the inflammatory molecules nitric oxide (NO) and TNF-α in cell culture supernatants of primary rat microglia (47) , and that progesterone, one of the neurosteroids, can reduce the expression of TNF-α and IL-1β in cultured microglia (14) .
Previous studies have demonstrated that IL-1β can enhance AMPA-or NMDA-induced currents, and suppress GABA-and glycine-induced currents (17) . As IL-1β is expressed by both astrocytes and microglia (1), and TSPO is upregulated in astrocytes and microglia (43) , diazepam may first bind with TSPO located in glial cells, inhibiting their cytokines release, then modulated the function of neurons. A previous study has reported that after peripheral nerve injury, microglia cells are activated within 24 h after injury in the spinal dorsal horn, whereas astrocyte activation occurs later than microglial, around 4 days post-injury (36) , suggesting that microglia cells are critical for initiation and astrocytes for the maintenance of neuropathic pain. In the present study, diazepam, Ro5-4864 or pregnenolone was injected 9 d after L5 SNL, when the neuropathcic pain had been established. These drugs may have first influenced astrocytes, then modulated the function of neurons. Direct effects on neurons could not be excluded, as TSPO is also located in neurons, although it is not up-regulated after L5 SNL (43) .
Previous reports have shown that TSPO and their endogenous ligands, the diazepam-binding inhibitor derived-peptides, are present in Schwann cells in the peripheral nervous system. This expression is increased after nerve lesion, and returns to normal pattern when regeneration is complete (20) . In the present study, though we did not evaluate the changes in the peripheral system after intraperitoneal injection of diazepam, TSPO located in damaged nerves and dorsal root ganglia may also be involved in facilitating nerve remyelination and regeneration via neurosteroid synthesis, thus resulted in a long-term protection of the nerve, and relieved the neuropathic pain induced by L5 SNL. Previous studies have reported that TSPO level in the brain was increased in patients with chronic low back pain (23) and that diazepam can readily be distributed into the different regions of brain tissues (16) , it is possible that diazepam also exerts effects via binding to recepors in the brain.
Thus, the effects of a single injection of diazepam on neuropathic pain might be a consequence of the TSPO-dependent increased neurosteroids levels, which then inhibits the production of cytokines and at last modulates the function of GABAA, AMPA, NMDA and receptors. In conclusion, in addition to CBR, TSPO-mediated neurosteroid synthesis may play an important role in the effects of diazepam on neuropathic pain.
